← Insider buys
RETA

Reata Pharmaceuticals Inc

CEO James Warren Huff sold $5.5M of Reata Pharmaceuticals Inc

Sold$5,456,115
$86.61Price
63,000Shares
−36%Stake

What RETA did after the filing

Prices for RETA after this filing aren't in yet.

Traded Fri, Sep 27. Filed Mon, Sep 30, 11:18 AM ET, during the session. Not investment advice.